.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
Chubb
Teva
Accenture
US Department of Justice
Express Scripts
Boehringer Ingelheim
Farmers Insurance
UBS

Generated: December 17, 2017

DrugPatentWatch Database Preview

PROZAC Drug Profile

« Back to Dashboard

When do Prozac patents expire, and what generic alternatives are available?

Prozac is a drug marketed by Eli Lilly And Co and Lilly and is included in four NDAs. There are four patents protecting this drug.

This drug has twenty-six patent family members in twenty-three countries.

The generic ingredient in PROZAC is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Seventy-two suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eli Lilly And CoPROZACfluoxetine hydrochlorideCAPSULE;ORAL018936-006Dec 23, 1992AB1RXYesNo► Subscribe► Subscribe► Subscribe
Eli Lilly And CoPROZACfluoxetine hydrochlorideCAPSULE;ORAL018936-004Jun 15, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Eli Lilly And CoPROZACfluoxetine hydrochlorideCAPSULE;ORAL018936-001Dec 29, 1987AB1RXYesNo► Subscribe► Subscribe► Subscribe
LillyPROZACfluoxetine hydrochlorideSOLUTION;ORAL020101-001Apr 24, 1991DISCNYesNo► Subscribe► Subscribe► Subscribe
LillyPROZAC WEEKLYfluoxetine hydrochlorideCAPSULE, DELAYED REL PELLETS;ORAL021235-001Feb 26, 2001ABRXYesYes► Subscribe► SubscribeY► Subscribe
Eli Lilly And CoPROZACfluoxetine hydrochlorideCAPSULE;ORAL018936-006Dec 23, 1992AB1RXYesNo► Subscribe► Subscribe► Subscribe
Eli Lilly And CoPROZACfluoxetine hydrochlorideCAPSULE;ORAL018936-001Dec 29, 1987AB1RXYesNo► Subscribe► Subscribe► Subscribe
Eli Lilly And CoPROZACfluoxetine hydrochlorideCAPSULE;ORAL018936-003Jun 15, 1999ABRXYesYes► Subscribe► Subscribe► Subscribe
Eli Lilly And CoPROZACfluoxetine hydrochlorideCAPSULE;ORAL018936-003Jun 15, 1999ABRXYesYes► Subscribe► Subscribe► Subscribe
LillyPROZACfluoxetine hydrochlorideTABLET;ORAL020974-002Mar 9, 1999DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: PROZAC

Country Document Number Estimated Expiration
South Africa200006815► Subscribe
New Zealand507980► Subscribe
Malaysia127938► Subscribe
Poland344331► Subscribe
Eurasian Patent Organization004539► Subscribe
European Patent Office0958824► Subscribe
China1154496► Subscribe
Turkey200003443► Subscribe
Japan2002516282► Subscribe
China1311681► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
Fuji
Accenture
Colorcon
Federal Trade Commission
Chubb
Express Scripts
Deloitte
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot